WTA
HARP

Washington Trust Advisors’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Washington Trust Advisors’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9
Closed -$1K – 1034
2021
Q4 		$1K Buy
+9
New +$614 ﹤0.01% 995

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Washington Trust Advisors's HARP Position: Q1 2022 in Review

Washington Trust Advisors sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2022, closing a stake of 9 shares — an estimated $1K sold.

Washington Trust Advisors first reported a position in HARP in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 79 funds tracked by Wall St. Rank hold HARP as of Q1 2022.

  • Washington Trust Advisors reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Washington Trust Advisors sold 9 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Washington Trust Advisors first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Washington Trust Advisors's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Washington Trust Advisors's 13F filing for Q1 2022, filed 5 May 2022.